Literature DB >> 2410005

Psoriasis: maintenance of an intact monolayer basal cell differentiation compartment in spite of hyperproliferation.

I M Leigh, K A Pulford, F C Ramaekers, E B Lane.   

Abstract

Frozen sections of punch biopsies from normal epidermis and psoriatic involved and uninvolved epidermis have been examined immunocytochemically using a panel of anti-keratin monoclonal antibodies with various specificities in the skin. Since psoriasis is thought to involve hyperproliferative expansion of the basal compartment from one to about three cell layers in thickness, the samples were screened with antibodies to intermediate filament determinants associated with basal cells, suprabasal cells and hyperproliferating keratinocyte-derived cell lines, respectively. The basal-suprabasal division was observed to be intact, with only one layer of basal cells demarcated by the specific antibodies used under all circumstances. This suggests that (a) psoriatic "basal cell hyperproliferation' may not specifically involve the basal cell compartment containing the stem cells, but rather a population of amplifying transit cells which are predominantly suprabasal, and that (b) while keratinocyte differentiation begins as the cells lose contact with the basal lamina, the first stages at least of differentiation are not dependent on the loss of the capacity to divide.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2410005     DOI: 10.1111/j.1365-2133.1985.tb02044.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  28 in total

1.  Mathematical models of hierarchically structured cell populations under equilibrium with application to the epidermis.

Authors:  Nicholas J Savill
Journal:  Cell Prolif       Date:  2003-02       Impact factor: 6.831

2.  Binding of antibodies to nonhistone nucleoproteins on keratinocytes in suspensions.

Authors:  P J Velthuis; E G Wildschut; H Baart de la Faille; W A van Vloten; H van Weelden; L Kater
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

3.  Effects of amiprilose hydrochloride on the components of human skin equivalents.

Authors:  J C Hevelone; S D Dimitrijevich; R W Gracy
Journal:  In Vitro Cell Dev Biol       Date:  1991-05

4.  Detection of a heterogeneity of basal keratinocytes in human hyperpapillomatous epidermis: a monoclonal antibody study.

Authors:  R Buidin; J Golstein; D Parent; M Heenen
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

5.  Dolichos biflorus agglutinin (DBA) reveals a similar basal cell differentiation in normal and psoriatic epidermis.

Authors:  A L Kariniemi; I Virtanen
Journal:  Histochemistry       Date:  1989

6.  Prodifferentiation, anti-inflammatory and antiproliferative effects of delphinidin, a dietary anthocyanidin, in a full-thickness three-dimensional reconstituted human skin model of psoriasis.

Authors:  Jean Christopher Chamcheu; Harish C Pal; Imtiaz A Siddiqui; Vaqar M Adhami; Seyoum Ayehunie; Brendan T Boylan; Felicite K Noubissi; Naghma Khan; Deeba N Syed; Craig A Elmets; Gary S Wood; Farrukh Afaq; Hasan Mukhtar
Journal:  Skin Pharmacol Physiol       Date:  2015-01-22       Impact factor: 3.479

Review 7.  Psoriatic science.

Authors:  C M Rowland Payne
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-07

8.  Inhibition of psoriatic cell proliferation in in vitro skin models by amiprilose hydrochloride.

Authors:  M L Chapman; S D Dimitrijevich; J C Hevelone; D Goetz; J Cohen; G E Wise; R W Gracy
Journal:  In Vitro Cell Dev Biol       Date:  1990-10

9.  Topical application of calcitriol alters expression of filaggrin but not keratin K1 in mouse epidermis.

Authors:  C Lützow-Holm; A Heyden; H S Huitfeldt; P Brandtzaeg; O P Clausen
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

Review 10.  Immunopathogenic mechanisms in psoriasis.

Authors:  J E Gudjonsson; A Johnston; H Sigmundsdottir; H Valdimarsson
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.